| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/24/2026 | ±4.6% | -1.9% | over-priced |
| 04/24/2026 | ±5.0% | -1.8% | over-priced |
| 07/29/2025 | ±4.7% | +1.1% | over-priced |
| 04/24/2025 | ±4.0% | +6.6% | under-priced |
| 10/23/2024 | ±2.1% | +4.0% | under-priced |
| 07/24/2024 | ±3.4% | -0.0% | over-priced |
| 04/24/2024 | ±2.6% | +5.6% | under-priced |
| 10/25/2023 | ±1.9% | -3.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.14 | $5.5B | $2.0B |
| Q1 FY2026 | $1.68 | $4.8B | $1.5B |
| Q4 FY2025 | — | $0 | $0 |
| Q2 FY2025 | $1.41 | $4.4B | $1.3B |
Texas Instruments Incorporated (TXN) reports in 109 days, with the next report estimated for 12/30/2026. Across the last 8 reports, options priced an average ±3.5% earnings move while the stock actually moved 3.1% on average — the market has been roughly fair on TXN's earnings risk. Fundamentals into the print: EPS up 67.2% year-over-year, revenue up 34.3%. QuantLogix's live 5-factor engine currently reads TXN as a buy at 73/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →